Globus Medical Inc.
corporate_fare Company Profile
Globus Medical Inc. (NYSE:GMED) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for GMED at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for GMED spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Globus Medical 10-Q: Q3 Sales Slip 0.7% to $763.7M, Buyback Raised $500M
- Globus Medical Cuts 2026 Revenue Guidance to $3.09B, Adds $500M to Buyback
- Globus Medical Posts 3Q EPS of $1.04
- Globus Medical Buys Synaptive Medical to Bolster Cranial Neurosurgery Franchise
- Globus Medical Buys Higgs Boson Health to Add AI-Driven Digital Solutions
Financial Snapshot
Short Interest & Short Volume
8.12 days to coverFINRA reported short interest of 9,455,426 shares in GMED as of the October 30, 2026 settlement, a 15.5% increase from the prior period — about 8.1 days to cover at its recent average daily volume. On November 20, 2026, 41.0% of GMED volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.